Article metrics

Original research
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma

 

Online download statistics by month:

Online download statistics by month: November 2022 to April 2024

AbstractFullPdf
Nov 2022606013
Dec 2022535539226
Jan 202343443451
Feb 202314314343
Mar 2023949544
Apr 2023737341
May 2023727336
Jun 2023606021
Jul 2023424225
Aug 2023666632
Sep 2023646425
Oct 2023828346
Nov 2023858533
Dec 2023727235
Jan 2024737463
Feb 2024939333
Mar 2024787876
Apr 2024717141
Total21972205884